Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AGIO Agios Pharmaceuticals, Inc.

休市中 05-17 16:00:00 EDT

34.34

-0.66

-1.89%

盘后34.34

+0.000.00%

16:05 EDT

最高35.02	最低34.07	成交量65.49万
今开35.00	昨收35.00	日振幅2.70%
总市值19.50亿	流通市值16.57亿	总股本5,677万
成交额2,256万	换手率1.36%	流通股本4,826万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AGIO","market":"US","secType":"STK","nameCN":"Agios Pharmaceuticals, Inc.","latestPrice":34.34,"timestamp":1715976000000,"preClose":35,"halted":0,"volume":654883,"hourTrading":{"tag":"盘后","latestPrice":34.34,"preClose":34.34,"latestTime":"16:05 EDT","volume":24494,"amount":841124.29,"timestamp":1715976325817},"delay":0,"floatShares":48261829,"shares":56772966,"eps":-6.304535,"marketStatus":"休市中","marketStatusCode":7,"change":-0.66,"latestTime":"05-17 16:00:00 EDT","open":35,"high":35.015,"low":34.07,"amount":22555666.272772,"amplitude":0.027,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.304535,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1374638400000,"adjPreClose":35,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":34.34,"preClose":34.34,"latestTime":"16:05 EDT","volume":24494,"amount":841124.29,"timestamp":1715976325817},"volumeRatio":1.3259645126334618},"requestUrl":"/m/hq/s/AGIO","defaultTab":"news","newsList":[{"id":"2429114352","title":"Agios Pharmaceuticals, Inc.盘中异动 急速拉升5.00%报31.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429114352","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429114352?lang=zh_cn&edition=full","pubTime":"2024-04-24 01:08","pubTimestamp":1713892085,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日01时08分，Agios Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.00%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.68%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为2608.87%、180.30%、50.88%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd C/Wts 25/01/2029、Palisade Bio, Inc.，振幅分别为80.08%、56.09%、45.43%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240108057922b712&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240108057922b712&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426589199","title":"坎托菲茨杰拉德公司：重申Agios Pharmaceuticals(AGIO.US)增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426589199","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426589199?lang=zh_cn&edition=full","pubTime":"2024-04-09 20:36","pubTimestamp":1712666183,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申Agios Pharmaceuticals(AGIO.US)增持评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409203625875a043c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409203625875a043c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414388788","title":"Agios Pharmaceuticals Inc盘中异动 快速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414388788","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414388788?lang=zh_cn&edition=full","pubTime":"2024-02-28 01:23","pubTimestamp":1709054607,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日01时23分，Agios Pharmaceuticals Inc股票出现波动，股价急速上涨5.05%。Agios Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Janux Therapeutics Inc、Viking Therapeutics Inc、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Scisparc Ltd、Zyversa Therapeutics Inc、Galera Therapeutics Inc较为活跃，换手率分别为359.34%、198.03%、38.99%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Janux Therapeutics Inc、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为169.78%、104.30%、75.00%。Agios Pharmaceuticals Inc公司简介：Agios Pharmaceuticals Inc是一家生物制药公司，致力于开发针对癌症和罕见代谢遗传疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402280123277a475931&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402280123277a475931&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413767766","title":"Agios Pharmaceuticals Inc盘中异动 早盘股价大涨5.07%报31.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413767766","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413767766?lang=zh_cn&edition=full","pubTime":"2024-02-23 22:57","pubTimestamp":1708700243,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日22时57分，Agios Pharmaceuticals Inc股票出现波动，股价大幅拉升5.07%。截至发稿，该股报31.29美元/股，成交量14.9166万股，换手率0.27%，振幅4.57%。Agios Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为1.04%。Agios Pharmaceuticals Inc公司简介：Agios Pharmaceuticals Inc是一家生物制药公司，致力于开发针对癌症和罕见代谢遗传疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022322572387e72b0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022322572387e72b0b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413273894","title":"美国研究综述-Biomarin Pharmaceutical、Intuit、Penumbra","url":"https://stock-news.laohu8.com/highlight/detail?id=2413273894","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413273894?lang=zh_cn&edition=full","pubTime":"2024-02-23 15:28","pubTimestamp":1708673314,"startTime":"0","endTime":"0","summary":"    路透社2月23日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Biomarin Pharmaceutical、Intuit 和 Penumbra。要闻             * Biomarin Pharmaceutical Inc   ：Piper Sandler将目标价从115美元下调至107美元             * Intuit Inc   ：Susquehanna将目标价从700美元上调至775美元             * Penumbra Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413210769","title":"Agios Pharmaceuticals Inc盘中异动 股价大涨5.30%报28.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413210769","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413210769?lang=zh_cn&edition=full","pubTime":"2024-02-22 23:29","pubTimestamp":1708615766,"startTime":"0","endTime":"0","summary":"北京时间2024年02月22日23时29分，Agios Pharmaceuticals Inc股票出现波动，股价大幅拉升5.30%。截至发稿，该股报28.22美元/股，成交量10.4536万股，换手率0.19%，振幅5.52%。Agios Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.78%。Agios Pharmaceuticals Inc公司简介：Agios Pharmaceuticals Inc是一家生物制药公司，致力于开发针对癌症和罕见代谢遗传疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240222232927791384ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240222232927791384ec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411686106","title":"美国研究综述-阿尔伯马尔、Dropbox、英伟达","url":"https://stock-news.laohu8.com/highlight/detail?id=2411686106","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411686106?lang=zh_cn&edition=full","pubTime":"2024-02-16 21:53","pubTimestamp":1708091615,"startTime":"0","endTime":"0","summary":"    路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，包括 Albemarle、Dropbox 和 Nvidia。要闻 * Albemarle Corp   ：摩根大通将目标价从130美元下调至115美元  * Bloom Energy Corp   ：KeyBanc将其评级从 \"增持 \"下调至 \"行业权重\"。* Dropbox Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Nvidia Corp   ：奥本海默将目标价从650美元上调至850美元  * Tyler Technologies Inc   ：Piper Sandler将目标价从480美元上调至520美元  以下是路透社周五报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411251632","title":"美国研究综述-英伟达、Albemarle、Dropbox","url":"https://stock-news.laohu8.com/highlight/detail?id=2411251632","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411251632?lang=zh_cn&edition=full","pubTime":"2024-02-16 17:25","pubTimestamp":1708075529,"startTime":"0","endTime":"0","summary":"    路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，包括 Albemarle、Dropbox 和 Nvidia。要闻  * Albemarle Corp   ：摩根大通将目标价从130美元下调至115美元  * Deere & Co   ：大和资本市场将目标价从425美元下调至400美元  * Dropbox Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411635884","title":"美国研究综述-阿尔伯马尔、Dropbox、泰勒科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2411635884","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411635884?lang=zh_cn&edition=full","pubTime":"2024-02-16 15:19","pubTimestamp":1708067998,"startTime":"0","endTime":"0","summary":"    路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，包括 Albemarle、Dropbox 和 Tyler Technologies。要闻  * Albemarle Corp   ：摩根大通将目标价从130美元下调至115美元  * Deere & Co   ：大和资本市场将目标价从425美元下调至400美元  * Dropbox Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Nvidia Corp   ：奥本海默将目标价从650美元上调至850美元              * Tyler Technologies Inc   ：Piper Sandler将目标价从480美元上调至520美元  以下是路透社周五报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agios.com","stockEarnings":[{"period":"1week","weight":0.0406},{"period":"1month","weight":0.1829},{"period":"3month","weight":0.2954},{"period":"6month","weight":0.5427},{"period":"1year","weight":0.3305},{"period":"ytd","weight":0.542}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Agios Pharmaceuticals, Inc.于2007年8月7日在特拉华州注册成立。该公司是一家生物制药公司，致力于通过细胞代谢领域的领导地位改变患者的生活，目标是为罕见病创造差异化药物，重点是经典血液学。","yearOnYearQuotes":[{"month":1,"riseRate":0.818182,"avgChangeRate":0.042769},{"month":2,"riseRate":0.636364,"avgChangeRate":0.059258},{"month":3,"riseRate":0.545455,"avgChangeRate":0.003251},{"month":4,"riseRate":0.545455,"avgChangeRate":0.006144},{"month":5,"riseRate":0.545455,"avgChangeRate":0.044059},{"month":6,"riseRate":0.6,"avgChangeRate":0.032699},{"month":7,"riseRate":0.3,"avgChangeRate":-0.034242},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.049224},{"month":9,"riseRate":0.545455,"avgChangeRate":0.047807},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.015381},{"month":11,"riseRate":0.636364,"avgChangeRate":0.038309},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.013921}],"exchange":"NASDAQ","name":"Agios Pharmaceuticals, Inc.","nameEN":"Agios Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Agios Pharmaceuticals, Inc.(AGIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Agios Pharmaceuticals, Inc.,AGIO,Agios Pharmaceuticals, Inc.股票,Agios Pharmaceuticals, Inc.股票老虎,Agios Pharmaceuticals, Inc.股票老虎国际,Agios Pharmaceuticals, Inc.行情,Agios Pharmaceuticals, Inc.股票行情,Agios Pharmaceuticals, Inc.股价,Agios Pharmaceuticals, Inc.股市,Agios Pharmaceuticals, Inc.股票价格,Agios Pharmaceuticals, Inc.股票交易,Agios Pharmaceuticals, Inc.股票购买,Agios Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Agios Pharmaceuticals, Inc.(AGIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况